Deliver Your News to the World

FiberChoice plus multivitamins issues allergy alert


WEBWIRE

GlaxoSmithKline (GSK) Consumer Healthcare, marketers of FiberChoiceŽ fiber supplement is recalling the newest variant of FiberChoiceŽ plus Multivitamins fiber supplement. This recall affects 90 count (16oz.) plastic bottles with the UPC #5714500581, which is located on the side of the bottle in black lettering.

This recall was initiated after we discovered fish gelatin, a known allergen, contained in one of the raw materials of the product, which was not declared on the product label for the multivitamins being recalled. The fish gelatin consists of the following species of fish: cod, pollock, hake, cusk, haddock, redfish, sole, and flounder.


No other FiberChoice fiber supplement products are affected by this recall.


To date, there have been no reports of adverse reactions due to fish allergies with this specific product. There is a possible health risk to consumers with both known and previously unknown fish allergies. Consumers with fish allergy sensitivities run the risk of a serious or life threatening allergic reaction if they consume the product and should not take this product. If consumers experience a reaction after ingesting this product, they should seek medical attention.


The health and safety of our consumers is of utmost importance, and we would like to assure consumers that GSK Consumer Healthcare is working to correct this allergen labeling omission.


PLEASE NOTE: GSK Consumer Healthcare estimates the recall involves approximately 144,000 plastic bottles. This product was recently shipped to major retailers, including food and drug and mass merchandisers beginning on January 15, 2007.


Consumers who have purchased the new FiberChoice plus Multivitamins fiber supplement should return it to the retail store where it was purchased for a full refund. Consumers with questions about the product or this recall are encouraged to call GlaxoSmithKline Consumer Healthcare toll-free at 1-800-819-0681.



WebWireID30225





This news content was configured by WebWire editorial staff. Linking is permitted.

News Release Distribution and Press Release Distribution Services Provided by WebWire.